Valuation : Terumo Corporation

Market Cap 3,297B 21.32B 18.37B 17.34B 15.79B 29.49B 2,038B 29.79B 205B 79.39B 1,038B 80.19B 78.43B P/E 2027 *
16.7x
P/E 2028 * 17.2x
Enterprise Value 3,343B 21.62B 18.63B 17.59B 16.01B 29.91B 2,066B 30.2B 208B 80.5B 1,053B 81.31B 79.52B EV / Sales 2027 *
2.66x
EV / Sales 2028 * 2.44x
Free-Float
97.07%
Yield 2027 *
1.66%
Yield 2028 * 1.82%
1 week-8.34%
Current month-7.16%
1 month-11.23%
3 months-0.45%
6 months+10.41%
Current year+0.45%
1 week 12.16
Extreme 12.155
13.29
1 month 12.16
Extreme 12.155
14.32
3 years 10.06
Extreme 10.065
19.7
5 years 10.06
Extreme 10.065
21.04
10 years 7.76
Extreme 7.7605
21.04
Manager TitleAgeSince
Chief Executive Officer 62 2024-03-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 2022-03-31
Director/Board Member 63 2019-06-20
Director/Board Member 75 2020-06-24
Change 5-day change 1-year change 3-year change Capi.($)
-0.73%-6.87%-17.75%-8.54% 21.78B
-1.78%-6.44%-21.67%+2.61% 182B
-0.29%-0.61%-2.60%+14.58% 118B
-0.73%-4.58%+7.46%+80.61% 61.7B
-0.32%-5.26%+12.44%+44.05% 50.55B
-1.88%-5.92%-7.39%-33.87% 48.98B
+0.75%-5.78%+7.79%-19.01% 31.65B
-4.88%-10.77% - - 29.87B
+2.17%+0.47%+36.59%-12.44% 23.71B
-1.46%-9.48%-14.50%+4.76% 21.78B
Average -0.65%-4.02%+0.04%+8.08% 63.1B
Weighted average by Cap. -0.26%-3.00%-5.56%+12.06%

Financials

2027 *2028 *
Net sales 1,259B 8.14B 7.01B 6.62B 6.03B 11.26B 778B 11.37B 78.34B 30.31B 396B 30.62B 29.94B 1,339B 8.66B 7.46B 7.04B 6.41B 11.98B 828B 12.1B 83.33B 32.24B 422B 32.57B 31.85B
Net income 195B 1.26B 1.09B 1.03B 933M 1.74B 120B 1.76B 12.13B 4.69B 61.38B 4.74B 4.64B 192B 1.24B 1.07B 1.01B 919M 1.72B 119B 1.73B 11.94B 4.62B 60.41B 4.67B 4.56B
Net Debt 45.99B 297M 256M 242M 220M 411M 28.43B 416M 2.86B 1.11B 14.48B 1.12B 1.09B -26.39B -171M -147M -139M -126M -236M -16.32B -238M -1.64B -636M -8.31B -642M -628M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
-
Date Price Change
26-09-10 €12.26 -0.73%
26-09-09 €12.35 -2.83%
26-09-08 €12.71 -2.68%
26-09-07 €13.06 -1.58%
26-09-04 €13.27 -0.79%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,235.00JPY
Average target price
3,140.77JPY
Spread / Average Target
+40.53%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!